While methylation alterations at MIR886 show a slightly weaker association with increased hazard in MYCN amplified NB tumours (Fig. 5A), methylation alterations at this region were found to be strongly associated with increased hazard in NB tumours with 11q deletion (Fig. 5B). The gene discussed is MYCN; the disease is neuroblastoma.